Research-Grade Navitoclax–BCL-2 Inhibitor for Bulk Orders

Mitora™Navitoclax is a high-purity BCL-2 inhibitor and research-grade senolytic compound widely used in aging, oncology, and cellular biology studies. Navitoclax selectively targets anti-apoptotic BCL-2 family proteins, promoting apoptosis in senescent cells and cancer models. Our product ensures consistency, stability, and reproducibility, making it ideal for in vitro and preclinical research. 

• High Purity: ≥99% pure Navitoclax for reliable and reproducible research results.
   
• Research-Grade Quality: Designed specifically for laboratory and preclinical studies.
   
• Bulk Supply Options: Flexible quantities available for B2B distributors, research institutions, and biotech companies.
   
• Certificate of Analysis (COA): Provided with each batch to verify purity and identity.
   
• Senolytic & Apoptosis Studies: Widely used in senescent cell clearance, cancer research, and BCL-2 pathway studies.

• Chemical Name: Navitoclax
   
• CAS Number: 923564-51-6
   
• Appearance: Off-white to pale-yellow crystalline powder
   
• Purity: ≥99%
   
• Storage: Store in a cool, dry place, protected from light

As a trusted senolytic compound supplier, Mitora™delivers Navitoclax–BCL-2 Inhibitor in bulk to laboratories and distributors worldwide. Our strict quality control, consistent production, and international shipping capabilities ensure researchers have reliable access to high-quality compounds.

• Preferred by academic research labs, biotech firms, and global B2B distributors.
   
• Fully compliant with research use only (RUO) regulations.
   
• Packaged securely for safe international transport.